Assessment of voiding dysfunction in Parkinson's disease by the international prostate symptom score

Araki, Isao; Kuno, Sadako
April 2000
Journal of Neurology, Neurosurgery & Psychiatry;Apr2000, p429
Academic Journal
No abstract available.


Related Articles

  • Efficacy and Tolerability of Imidafenacin, a Novel Anticholinergic Agent for Overactive Bladder, in Parkinson's Disease Patients with Nocturia. Utsumi, Hiroya; Ishimura, Yohei; Hatano, Tadashi; Tachibana, Masaaki; Terashi, Hiroo // International Medical Journal;Apr2013, Vol. 20 Issue 2, p136 

    Objective: Imidafenacin, a novel agent for overactive bladder, was studied in Parkinson's disease patients with urinary dysfunction, primarily nocturia, to confirm treatment efficacy and assess safety. Materials and Methods: Imidafenacin (0.1 mg b.i.d.) was taken orally after breakfast and...

  • Benign Prostatic Hyperplasia.  // Current Medical Literature: Urology;2008, Vol. 14 Issue 2, p37 

    The article presents abstracts of several studies related to benign prostatic hyperplasia, including an index of voiding dysfunction in men with benign prostatic enlargement, the effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with prostate...

  • Relationship between urinary symptoms and disease-related parameters in multiple sclerosis. Araki, I.; Matsui, M.; Ozawa, K.; Nishimura, M.; Kuno, S.; Saida, T. // Journal of Neurology;Aug2002, Vol. 249 Issue 8, p1010 

    Objective To find the prevalence of voiding dysfunction in patients with multiple sclerosis and to examine the relationship between the voiding dysfunction and various parameters of the disease (disease severity, disease duration, lesion site, age and sex). Methods Using the International...

  • Role of voiding and storage symptoms for the quality of life before and after treatment in men with voiding dysfunction. Sountoulides, Petros; van Dijk, Marleen M.; Wijkstra, Hessel; de la Rosette, Jean J. M. C. H.; Michel, Martin Christian // World Journal of Urology;Feb2010, Vol. 28 Issue 1, p3 

    Previous studies on associations between voiding dysfunction and quality of life (QoL) have largely been limited to baseline data. Therefore, we have explored associations between Qmax and voiding and storage sub-scores of the International Prostate Symptom Score (IPSS) before and after...

  • Prevalence and factors associated with uncomplicated storage and voiding lower urinary tract symptoms in community-dwelling Australian men. Martin, Sean; Haren, Matthew; Marshall, Villis; Lange, Kylie; Wittert, Gary // World Journal of Urology;Apr2011, Vol. 29 Issue 2, p179 

    Purpose: To determine the prevalence of, and associated risk factors for, voiding and storage lower urinary tract symptoms (LUTS) in a population-based sample of Australian men. Methods: Data were collected from 1,103 men randomly selected, community-dwelling men, as part of the Florey Adelaide...

  • Effect of Transurethral Resection of the Prostate on Storage Symptoms in Patients with Benign Prostatic Hyperplasia of Less than 30 ml. Yu Jin Kang; Ki Ho Kim; Youngjin Seo; Kyung Seop Lee // World Journal of Men's Health;Apr2013, Vol. 31 Issue 1, p64 

    Purpose: Many patients with benign prostatic hyperplasia (BPH) have not only voiding symptoms but also storage symptoms. Despite the many types of treatment that have been developed for BPH, storage symptoms persist. We conducted an assessment of the efficacy of transurethral resection of the...

  • Urinary Dysfunction in Progressive Supranuclear Palsy Compared with Other Parkinsonian Disorders. Yamamoto, Tatsuya; Tateno, Fuyuki; Sakakibara, Ryuji; Furukawa, Shogo; Asahina, Masato; Uchiyama, Tomoyuki; Hirano, Shigeki; Yamanaka, Yoshitaka; Fuse, Miki; Koga, Yasuko; Yanagisawa, Mitsuru; Kuwabara, Satoshi // PLoS ONE;2/17/2016, Vol. 11 Issue 2, p1 

    Background: Autonomic urinary dysfunction affects patients with progressive supranuclear palsy (PSP); however, the severity and prevalence of urinary dysfunctions in these patients compared with those observed in patients with Parkinson’s disease (PD) and multiple system atrophy (MSA)...

  • Comparing Monotherapy with Tadalafil or Tamsulosin and Their Combination Therapy in Men with Benign Prostatic Hyperplasia: A Randomized Clinical Trial. Karami, Hossein; Hassanzadeh-Hadad, Amin; Fallah-Karkan, Morteza // Urology Journal;Nov/Dec2016, Vol. 13 Issue 6, p2920 

    Purpose: To compare monotherapy with tadalafil or tamsulosin and their combination therapy in men with benign prostatic hyperplasia and erectile dysfunction by comparing IPSS score, prostate volume and Qmax and some other outcomes. Materials and Methods: This randomized, single-blind, paralleled...

  • Focal cryosurgical ablation of the prostate: a single institute's perspective. Hale, Zachary; Miyake, Makito; Palacios, Diego Aguilar; Rosser, Charles J. // BMC Urology;2013, Vol. 13 Issue 1, p1 

    Background: With the stage migration of prostate cancer witnessed in the late 1990's and early 2000's along with the persistent morbidities associated with prostatectomy and radiation therapy, the concept of focal prostate cancer treatment remains quite attractive. Herein we evaluate the...

  • Impact of nocturia on disease-specific quality of life for men with localized prostate cancer. Namiki, Shunichi; Takegami, Misa; Ishidoya, Shigeto; Numata, Isao; Arai, Yoichi // Quality of Life Research;Dec2011, Vol. 20 Issue 10, p1609 

    Objectives: We assessed the impact of nocturia on the general and disease-specific health-related quality of life (HRQOL) for men with localized prostate cancer. Materials and methods: A total of 620 men with prostate cancer were enrolled to our study. All of the subjects completed the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics